The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after acute lymphoblastic leukemia therapy completed;Wpływ wieku, płci oraz modyfikacji protokołów leczniczych na rozwój fizyczny dzieci i młodzieży po zakończonym leczeniu ostrej białaczki limfoblustycznej

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 9, Issue 1, 2003, Pages 41-47

  Krawczuk Rybak, Maryna ^a   Kaliszewski, Jacek ^a   Kitszel, Anna ^a  

^a Klinika Okulistyki Dzieciecej   (Poland)

Author keywords

Acute lymphoblastic leukemia; Body mass index; Chemotherapy; Children; Growth; Radiotherapy

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BODY MASS; CHILD; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL DEVELOPMENT; PROPHYLAXIS; RADIATION DOSE; SCORING SYSTEM; SEX DIFFERENCE;

6-MERCAPTOPURINE; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BODY MASS INDEX; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FEMALE; GROWTH; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LONGITUDINAL STUDIES; METHOTREXATE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THIOGUANINE; VINCRISTINE;

EID: 0042736083     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adan L., Souberbielle J.-C., Blanche S. i wsp.: Adult height after cranial irradiation with 24 Gy:. factors and markers of height loss. Acta Pediatr., 1996, 85, 1096.
2. Ahmed S.F, Wallace W.H.B., Kelnar C.J.H.: An Anthropometric Study of Children during Intensive Chemotherapy for Acute Lymphoblastic Leukaemia. Horm. Res., 1997, 48, 178.
3. Arvidson J., Lonnerholm G., Turemo T. i wsp.: Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation. Pediatr. Hematol. Oncol., 2000, 17, 285.
4. Bakker B., Massa G.G., Oostdijk W. i wsp.: Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur. J. Pediatr., 2000, 159, 31.
5. Barr R.D., Halton J., Willan A. i wsp.: Impact of age and cranial irradiation on radiographic skeletal pathology in children with acute lymphoblastic leukemia. Med. Pediatr. Oncol., 1998, 30, 347.
6. Birkebaek N.H., Clausen N.: Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch. Dis. Child., 1998, 79, 161.
7. Birkebaek N.H., Fisker S., Clausen N. i wsp.: Growth and Endocrinological Disorders Up to 21 Years After Treatment for Acute Lymphoblastic Leukemia in Childhood. Med. Pediatr. Oncol., 1998, 30, 351.
8. Brennan B., Shalet S.M.: Endocrine late effects after bone marrow transplant. Br. J. Haematol., 2002, 118, 58.
9. Cohen A., Rovelli A., Bakker B. i wsp.: Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the working party for late effects - EBMT. Blood, 1998, 93, 4109.
10. Davies H.A., Didcock E., Didi M. i wsp.: Disproportionate short stature after cranial irradiation and combination chemotherapy for leukemia. Arch. Dis. Child., 1994, 70, 472.
11. Davies H.A., Didcock E., Didi M. i wsp.: Growth, puberty and obesity after treatment for laukaemia. Acta Paediatr., 1995, 411, supl., 45.
12. Dolezal K., Skoczeń S., Dziatkowiak H. i wsp.: Ocena wzrostu i masy ciala w czasie i po leczeniu ostrei białaczki limfoblastycznej u dzieci i mlodzleży. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego, 2001, 7, 89.
13. Groot-Loonen J.J., Setten P., Otten B.J. i wsp.: Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatr., 1996, 85, 1091.
14. Holm K., Nysom K., Hertz H. i wsp.: Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr., 1994, 83, 1287.
15. Leiper A.: Growth hormone deficiency in children treated for leukaemia. Acta Paediatr., 1995, 411, 41.
16. Melin A. E., Adan L., Leverger G. i wsp.: Growth hormone secretion, puberty and adult height after cranial irradiation wtih 18 Gy for leukaemia. Eur. J. Pediatr., 1998, 157, 703.
17. Mohnike K., Dörffel W., Timme J. i wsp.: Final height and puberty in 40 patients after antileukaemic treatment during childhood. Eur. J. Pediatr., 1997, 156, 272.
18. Murray R.D., Brennan B.M.D., Rahim A.: Survivors of childhood cancer: long-term endocrine and metabolic problems dwarf the growth disturbance. Acta Paediatr., 1999, 433, 5.
19. Murrary R.D., Darzy K.H., Gleeson H.K. i wsp.: GH-deficient survivors of childhood cancer: GH replacement during adult life. J. Clin. Endocrinol. Metab., 2002, 87, 129.
20. Ogilvy-Stuart A. L. Shalet S.M.: Effect of chemotherapy on growth. Acta Paediatr., 1995, supl. 52, 411.
21. Palczewska I., Szilagyi-Pagowska I.: Ocena rozwoju somatycznego dzieci i mlodzieży. Medycyna Praktyczna (Pediatria), 2002, 3, 1.
22. Román J., Villaizán C.J., Garcia-Foncillas J. i wsp.: Growth and growth hormone secretion on children with cancer treated with chemotherapy. J. Pediatr., 1997, 131, 105.
23. Sklar C.: Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr., 1995, 411, 57.
24. Spoudeas H.A.: Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur. J. Cancer, 2002, 38, 1748.